home All News open_in_new Full Article

Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S. mRNA-LNP vaccine litigation scheduled for September 2025 Reviewing pipeline and development plans for HBV programs Continued focus on efficient deployment of financial resources and personnel – terminated ATM program and implemented reduction of workforce by 57% […]


today 3 d. ago attach_file Culture

attach_file Other
attach_file Other
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture
attach_file Economics
attach_file Other
attach_file Economics
attach_file Other
attach_file Society
attach_file Culture
attach_file Economics
attach_file Culture
attach_file Other
attach_file Culture
attach_file Culture


ID: 3506907940
Add Watch Country

arrow_drop_down